morbidity mortality cystic fibrosis patients mainly attributed pulmonary infection inflammation chemokines play pivotal role inflammatory process correlation cystic fibrosis patients defined clear relationship defect cystic fibrosis transmembrane regulator cftr gene pulmonary inflammation established aim study assess serum chemokines levels cystic fibrosis patients correlate genotype pulmonary function tests clinical characteristics serum levels rantes monocyte chemoattractant measured NUMBER cystic fibrosis patients grouped according genotype group included NUMBER patients carried mutations associated pathological sweat test pancreatic insufficiency deltaf508 w1282x g542x n1303k s549r group b included NUMBER compound heterozygote patients carried mutation known cause mild disease borderline normal sweat test pancreatic sufficiency 384910kb c t 5t associations chemokine levels genotype pulmonary function pseudomonas aeruginosa colonization age sweat chloride level pancreatic nutritional status examined mean monocyte chemoattractant levels significantly higher group group b NUMBER NUMBER vs NUMBER NUMBER NUMBER NUMBER vs NUMBER NUMBER respectively p NUMBER difference rantes levels groups levels inversely related forced expiratory volume NUMBER s r p NUMBER association rantes monocyte chemoattractant levels pseudomonas colonization rate higher group patients group b NUMBER vs NUMBER p NUMBER relationship measured chemokines age sweat chloride levels pancreatic nutritional status study demonstrates association forced expiratory volume cystic fibrosis genotype elevated serum levels serve indicator early inflammatory process encourage initiation treatment genotype phenotype interleukin NUMBER protein NUMBER interleukin NUMBER protein NUMBER interleukin NUMBER NUMBER protein NUMBER interleukin NUMBER interleukin NUMBER anti inflammatory pg ml pg ml pg ml pg ml